PROF Christopher Rowe

PROF Christopher Rowe

Positions

Overview

OverviewText1

  • Professor Christopher Rowe BMBS, FRACP, MD, FAANMS is a nuclear medicine physician and neurologist, with over 20 years of experience in dementia research and patient care. He is the Director of Molecular Imaging Research at Austin Health, Melbourne, Professorial Fellow University of Melbourne, a NHMRC Practitioner Fellow and is the inaugural Director of the Australian Dementia Network. His research focus is molecular imaging of neurodegenerative diseases, particularly AD, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions. He has over 300 publications and is in the 2019 Highly Cited Researcher list of the top 1% world-wide for neuroscience with over 4,500 citations of his papers per year, and has received the 2011 US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the 2016 Christopher Clark Award for advancing human brain amyloid imaging.   

Publications

Selected publications

Research

Investigator on

Awards

Education and training

  • DMedSci, University of Melbourne 1990
  • BMBS, Flinders University of South Australia 1980

Supervision

Available for supervision

  • Y

Supervision Statement

  • Primary supervisor of 1-2 PhD students per year primarily located at Austin Health. The field is molecular imaging of neurodegenerative disease (i.e. neuroscience). 100% completion rate to date. Scholarship top up is provided.